Key result
Novel discharge risk score predicts six-month ACS mortality with 0.80 AUC, matching the GRACE score.
Why the study?
Risk assessment at hospital discharge has not received much consideration in prior risk scoring systems for ACS patients, creating a need for a reliable and simple tool to identify those at high mortality risk at discharge.
Does a novel risk score predict 6-month mortality in patients admitted with acute coronary syndrome?
Observational (n=1,012)
No
Does a novel risk score predict 6-month mortality in patients admitted with acute coronary syndrome?
Absolute Event Rate: 0.8% vs 0.78%
p-value: p=<0.05
A newly developed, simple 10-variable bedside risk score accurately predicts 6-month mortality in ACS patients at hospital discharge, performing non-inferiorly to the GRACE score.
May support discharge risk stratification in ACS; leaves open prospective validation versus GRACE.
BACKGROUND: In patients with ACS, risk assessment at hospital discharge has not received much consideration in prior risk scoring systems. Hence, there is a need for a reliable and simple tool to identify patients with high mortality risk at discharge form the hospital. METHODS: In a 1-year observational, prospective study, 1012 patients admitted with ACS were followed up for 6 months after discharge. From 26 potential variables, a new risk score to predict 6-month mortality was developed. RESULTS: A multi-variant Cox regression analysis with forward stepwise variable selection was performed and 10 highly significant independent predictors of 6-month mortality were identified. These include previous history of ACS, higher Killip class at admission, NYHA class at discharge, recurrent ischemia during hospital stay, heart failure, requiring ionotropic supports, requiring hemodialysis, presence of arrhythmia, left ventricular dysfunction detected on echocardiography and elevated admission blood glucose levels. Points were given to each variable and a total score was calculated. A risk score of 0-4 (low risk) predicted a mortality of 3.7%,a risk score of 5-15 (Intermediate risk) predicted a mortality of 16.4% and a risk score of 11-15 predicted a mortality of 32.0% over a 6-month period. The new risk score was noninferior to GRACE risk score in its predictive accuracy of 6-month mortality in the same cohort of patients (p < 0.05). CONCLUSION: The risk score developed in our study can be easily calculated at the bedside and is aimed at identifying high risk patients who require more intense follow up after discharge.
No takes yet. Share an insight, caveat, or question.
Padiyara et al. (2021) conducted an observational in Acute coronary syndrome (n=1,012). Novel risk score vs. GRACE risk score was evaluated on Predictive accuracy (AUC) for 6-month mortality (95% CI 0.75-0.85, p=<0.05). A novel 15-point risk score calculated at hospital discharge predicted 6-month mortality in patients with acute coronary syndrome with an AUC of 0.80, demonstrating noninferiority to the GRACE score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: